GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹ २,६५५.००
arrow_downward
-०.६६%(-१७.६०) 1D
नोभेम्बर १६, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹ २,६७३.००
High
₹ २,६८५.८०
Low
₹ २,६३६.५०
Mkt. cap
४.४७ खरब
Avg. vol.
८७.७७ हजार
Volume
९४.०७ हजार
Dividend
२.१५%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.२३
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
Open
₹ २,६७३.००
High
₹ २,६८५.८०
Low
₹ २,६३६.५०
Mkt. cap
४.४७ खरब
Avg. vol.
८७.७७ हजार
Volume
९४.०७ हजार
Dividend
२.१५%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.२३
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
ChartMill
·
१ घण्टा पहिले
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
३० मिनेट पहिले
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
The Korea Times
·
३ घण्टा पहिले
Wall Street slumps on AI jitters ahead of Nvidia results, Anthropic IPO
Stocktwits
·
३ घण्टा पहिले
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees३.१ हजार
Founded१९२४ नोभेम्बर १३
Headquarters-
SectorHealth Care
Industry-
Websiteindia-pharma.gsk.com